Optimizing the care of patients on PrEP
Patients taking PrEP are seen for regular follow up every three months. The resources provided below review standard testing and counselling provided in follow up, as well as detailed information on testing and treatment of sexually transmitted infections, and monitoring of kidney and bone health as part of ongoing PrEP patient follow up.
Patients taking PrEP are seen for regular follow up every 3 months. This presentation reviews standard testing and counselling provided in follow up, and common patient issues to manage as part of follow up care.
Testing and treatment of sexually transmitted infections is a key aspect of ongoing PrEP follow up. Learn more about how to test for and treat gonorrhea, chlamydia, and syphilis in the videos below.
Syphilis testing and management can be more complicated than treatment for other sexually transmitted infections. In this first presentation, learn about different tests used to diagnose syphilis and how to interpret test results.
Now that you’ve tested your patient, learn about syphilis staging.
Syphilis testing and management can be more complicated than treatment for other sexually transmitted infections. In this second presentation, learn about the four stages of syphilis, how to identify them, and how to manage patients based on stage of infection.
Now that you’ve learned about how to identify the stage of syphilis, learn about how to treat syphilis in your patients.
Syphilis testing and management can be more complicated than treatment for other sexually transmitted infections. In this third presentation, learn about the different treatment options based on patient stage and options for patients who are allergic to penicillin.
Now that you’ve learned how to treat your patient, learn about syphilis follow up care.
Syphilis testing and management can be more complicated than treatment for other sexually transmitted infections. In this fourth presentation, learn about how to follow-up with patients post treatment, including follow-up testing and options for patients where initial treatment may have been ineffective.
To learn more about how to test for and treat other common sexually transmitted infections, review our slides on gonorrhea and chlamydia testing.
Tenofovir disoproxil fumarate has been linked to reduced kidney functions in some patients. This presentation reviews the research on tenofovir disoproxil fumarate’s impact on kidney health, how to screen and monitor kidney health in patients starting or taking TDF as PrEP, and when to discontinue use of TDF.
Tenofovir disoproxil fumarate has been linked to reduced bone density in some patients. This presentation reviews the research on tenofovir disoproxil fumarate’s impact on bone health, how to screen and monitor bone health in patients starting or taking TDF as PrEP, and management of osteopenia and osteoporosis.
This website provides general information about Pre-Exposure Prophylaxis for HIV. This site is not intended to be a substitute for professional medical advice, diagnosis, or treatment. We strongly urge individuals considering starting PrEP to consult with a qualified medical practitioner prior to undertaking any decision, use or action of a medical nature.